KAYLEE ADAMS: Open Payments
NPI 1942943246 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 69 payments from 14 companies in 2025. Trend: 2023 $1,014 · 2024 $596 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $220 |
| Janssen Biotech, Inc. | 16 | $168 |
| Ardelyx, Inc. | 16 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101 |
| Gilead Sciences, Inc. | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| PFIZER INC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $22 |
Products named: TREMFYA, IBSRELA, XIFAXAN, LINZESS, RINVOQ, VOQUEZNA, DUPIXENT, MAVYRET.
Industry payments across SC — which companies pay providers there.
